ABL001,
asciminib,
asciminib,
ABL-001,
UNII-L1F3R18W77,
ABL001,
L1F3R18W77,
1492952-76-7,
(R)-N-(4-(Chlorodifluoromethoxy)phenyl)-6-(3-hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-5-yl)nicotinamide,
Example 9,
Asciminib [USAN],
ABL001-NX,
GTPL8962,
SCHEMBL15388306,
VOVZXURTCKPRDQ-CQSZACIVSA-N,
ZINC150275965,
CS-7655,
DB12597,
SB18878,
HY-104010,
(R)-N-(4-(Chloro difluoromethoxy)phenyl)-6-(3-hydroxypyrrolidin-1-yl)-5-(1H-pyrazol-5-yl)nicotinamide,
AY7,
N-[4-[chloro(difluoro)methoxy]phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide,
(R)-N- (4-(chlorodifluoromethoxy)phenyl)- 6-(3- hydroxypyrrolidin-1- yl)-5- (1H-pyrazol- 5-yl)nicotinamide,
3-Pyridinecarboxamide, N-(4-(chlorodifluoromethoxy)phenyl)-6-((3R)-3-hydroxy-1-pyrrolidinyl)-5-(1H-pyrazol-3-yl)-,